Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.19.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net loss $ (47,194) $ (43,319)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 4,337 1,383
Deferred income taxes, net (1,821)  
Costs of warrants issued   207
Change in fair value of warrant liability (7) (93)
Provision for doubtful accounts 54 25
Stock-based compensation expense 16,049 9,963
Other (19)  
Changes in assets and liabilities:    
Accounts receivable 156 (8,327)
Expenditures billable to clients (3,472) (4,120)
Prepaid expenses and other current assets (953) (422)
Accounts payable (5,282) 6,040
Accrued media payments 3,189 8,126
Client advances 15,057 5,004
Other accrued liabilities 1,447 (271)
Other liabilities 31 837
Net cash used in operating activities (18,428) (24,967)
Cash flows from investing activities:    
Proceeds from sales of marketable securities 13,614 21,000
Capital expenditures (282) (3,543)
Intangible assets acquired (477) (629)
Acquisition of businesses, net of cash acquired (883) (9,627)
Net cash provided by investing activities 11,972 7,201
Cash flows from financing activities:    
Proceeds from common stock offerings, net 17,302 32,782
Proceeds from exercise of stock options 120  
Proceeds from issuances of stock under employee stock plans 602 1,566
Net cash provided by financing activities 18,024 34,348
Net increase in cash, cash equivalents and restricted cash 11,568 16,582
Cash, cash equivalents and restricted cash, beginning of period 38,776 29,545
Cash, cash equivalents and restricted cash, end of period $ 50,344 $ 46,127